Discussion: The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding
Plast Reconstr Surg
.
2018 Jul;142(1):250-251.
doi: 10.1097/PRS.0000000000004528.
Authors
Edward A Luce
1
,
Eric Swanson
1
Affiliation
1
From the University of Tennessee Health Science Center and private practice.
PMID:
29952904
DOI:
10.1097/PRS.0000000000004528
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants
Enoxaparin*
Fibrinolytic Agents
Humans
Risk
Venous Thromboembolism*
Venous Thrombosis
Substances
Anticoagulants
Enoxaparin
Fibrinolytic Agents